Litcius/Paper detail

Endothelial cells require functional FLVCR1a during developmental and adult angiogenesis

Sara Petrillo, Francesco De Giorgio, Francesca Bertino, Francesca Garello, Valeria Bitonto, Dario Livio Longo, Sonia Mercurio, Giorgia Ammirata, Anna Lucia Allocco, Veronica Fiorito, Deborah Chiabrando, Fiorella Altruda, Enzo Terreno, Paolo Provero, Luca Munaron, Tullio Genova, Ana Nóvoa, Ana Rita Carlos, Sílvia Cardoso, Moisés Mallo, Miguel P. Soares, Emanuela Tolosano

2023Angiogenesis22 citationsDOIOpen Access PDF

Abstract

The Feline Leukemia Virus Subgroup C Receptor 1a (FLVCR1a) is a transmembrane heme exporter essential for embryonic vascular development. However, the exact role of FLVCR1a during blood vessel development remains largely undefined. Here, we show that FLVCR1a is highly expressed in angiogenic endothelial cells (ECs) compared to quiescent ECs. Consistently, ECs lacking FLVCR1a give rise to structurally and functionally abnormal vascular networks in multiple models of developmental and pathologic angiogenesis. Firstly, zebrafish embryos without FLVCR1a displayed defective intersegmental vessels formation. Furthermore, endothelial-specific Flvcr1a targeting in mice led to a reduced radial expansion of the retinal vasculature associated to decreased EC proliferation. Moreover, Flvcr1a null retinas showed defective vascular organization and loose attachment of pericytes. Finally, adult neo-angiogenesis is severely affected in murine models of tumor angiogenesis. Tumor blood vessels lacking Flvcr1a were disorganized and dysfunctional. Collectively, our results demonstrate the critical role of FLVCR1a as a regulator of developmental and pathological angiogenesis identifying FLVCR1a as a potential therapeutic target in human diseases characterized by aberrant neovascularization.

Topics & Concepts

AngiogenesisBiologyZebrafishNeovascularizationCell biologyBlood vesselRegulatorEmbryonic stem cellCancer researchImmunologyPathologyMedicineGeneticsEndocrinologyGeneZebrafish Biomedical Research ApplicationsAngiogenesis and VEGF in CancerPlatelet Disorders and Treatments